Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience
Peter Kellman, Joel R Wilson, Hui Xue, W Patricia Bandettini, Sujata M Shanbhag, Kirk M Druey, Martin Ugander, Andrew E Arai, Peter Kellman, Joel R Wilson, Hui Xue, W Patricia Bandettini, Sujata M Shanbhag, Kirk M Druey, Martin Ugander, Andrew E Arai
Abstract
Background: Diffuse myocardial fibrosis, and to a lesser extent global myocardial edema, are important processes in heart disease which are difficult to assess or quantify with cardiovascular magnetic resonance (CMR) using conventional late gadolinium enhancement (LGE) or T1-mapping. Measurement of the myocardial extracellular volume fraction (ECV) circumvents factors that confound T1-weighted images or T1-maps. We hypothesized that quantitative assessment of myocardial ECV would be clinically useful for detecting both focal and diffuse myocardial abnormalities in a variety of common and uncommon heart diseases.
Methods: A total of 156 subjects were imaged including 62 with normal findings, 33 patients with chronic myocardial infarction (MI), 33 with hypertrophic cardiomyopathy (HCM), 15 with non-ischemic dilated cardiomyopathy (DCM), 7 with acute myocarditis, 4 with cardiac amyloidosis, and 2 with systemic capillary leak syndrome (SCLS). Motion corrected ECV maps were generated automatically from T1-maps acquired pre- and post-contrast calibrated by blood hematocrit. Abnormally-elevated ECV was defined as >2SD from the mean ECV in individuals with normal findings. In HCM the size of regions of LGE was quantified as the region >2 SD from remote.
Results: Mean ECV of 62 normal individuals was 25.4 ± 2.5% (m ± SD), normal range 20.4%-30.4%. Mean ECV within the core of chronic myocardial infarctions (without MVO) (N=33) measured 68.5 ± 8.6% (p<0.001 vs normal). In HCM, the extent of abnormally elevated ECV correlated to the extent of LGE (r=0.72, p<0.001) but had a systematically greater extent by ECV (mean difference 19 ± 7% of slice). Abnormally elevated ECV was identified in 4 of 16 patients with non-ischemic DCM (38.1 ± 1.9% (p<0.001 vs normal) and LGE in the same slice appeared "normal" in 2 of these 4 patients. Mean ECV values in other disease entities ranged 32-60% for cardiac amyloidosis (N=4), 40-41% for systemic capillary leak syndrome (N=2), and 39-56% within abnormal regions affected by myocarditis (N=7).
Conclusions: ECV mapping appears promising to complement LGE imaging in cases of more homogenously diffuse disease. The ability to display ECV maps in units that are physiologically intuitive and may be interpreted on an absolute scale offers the potential for detection of diffuse disease and measurement of the extent and severity of abnormal regions.
Figures
References
- Sado DM, Flett AS, Moon JC. Novel imaging techniques for diffuse myocardial fibrosis. Future Cardiol. 2011;7(5):643–50. doi: 10.2217/fca.11.45.
- Flett AS, Hayward MP, Ashworth MT. et al.Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122 2:138–44.
- Jerosch-Herold M, Sheridan DC, Kushner JD. et al.Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2008;295:H1234–42. doi: 10.1152/ajpheart.00429.2008.
- Kehr E, Sono M, Chugh S, Jerosch-Herold M. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging. 2008;24:61–8.
- Broberg CS, Chugh S, Conklin C, Sahn DJ, Jerosch-Herold M. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging. 2010;3:727–34. doi: 10.1161/CIRCIMAGING.108.842096.
- Schelbert E, Testa SM, Meier CG. et al.Myocardial Extracellular Volume Fraction Measurement by Gadolinium Cardiovascular Magnetic Resonance in Humans: Slow Infusion versus Bolus. J Cardiovasc Magn Reson. 2011;13:16. doi: 10.1186/1532-429X-13-16.
- Ugander M, Oki AJ, Hsu L-Y, Extracellular Volume Imaging by MRI Provides Insight into Overt and Subclinical Myocardial Pathology. Eur Heart J. 2012. Jan 24. [Epub ahead of print]
- Lee JJ, Liu S, Nacif MS, Ugander M, Kawel N, Sibley CT, Kellman P, Arai A, Bluemke DA. Myocardial T1 and extracellular volume fraction mapping at 3 Tesla. J Cardiovasc Magn Reson. 2011;13(1):75. doi: 10.1186/1532-429X-13-75.
- Arheden H, Saeed M, Higgins CB. et al.Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar mr imaging to quantify myocardial infarction: comparison with 99mtc-dtpa autoradiography in rats. Radiology. 1999;211:698–708.
- Druey KM, Greipp PR. Narrative review: the systemic capillary leak syndrome. Ann Intern Med. 2010;153(2):90–8.
- Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging. 2007;26:1081–6. doi: 10.1002/jmri.21119.
- Xue H, Shah S, Greiser A, Motion Correction for Myocardial T1 Mapping using Image Registration with Synthetic Image Estimation. Magn Res Med. published online: 29 AUG 2011.
- Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002;47:372–83. doi: 10.1002/mrm.10051.
- Klein C, Nekolla SG, Balbach T, Schnackenburg B, Nagel E, Fleck E, Schwaiger M. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging. 2004;20(4):588–93. doi: 10.1002/jmri.20164.
- Ugander M, Bagi PS, Oki AJ, Myocardial edema as detected by pre-contrast T1 and T2 MRI delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012. in press.
Source: PubMed